BRIEF published on 10/24/2025 at 18:35, 1 month 11 days ago Predilife Publishes its 2025 Half-Yearly Financial Report Artificial Intelligence Euronext Growth Personalized Medicine PREDILIFE 2025 Financial Report
BRIEF published on 10/09/2025 at 18:35, 1 month 26 days ago Predilife: Solid 2025 half-year results despite uncertainties Funding Half-year Results Turnover PREDILIFE Health Forecast
BRIEF published on 07/25/2025 at 18:05, 4 months 10 days ago Balance sheet as of June 30, 2025 of the PREDILIFE Liquidity Contract Liquidity Transactions PREDILIFE Pathologies FASD
BRIEF published on 07/22/2025 at 19:05, 4 months 13 days ago PREDILIFE COMPLETES A PRIVATE PLACEMENT OF €326,000 Private Placement Sales Growth OCEANE Dilution Of Shares Financial Horizon
BRIEF published on 07/03/2025 at 08:05, 5 months 1 day ago Predilife launches a private placement with a growth perspective Private Placement Sales Growth OCEANE PREDILIFE MammoRisk
BRIEF published on 06/25/2025 at 18:05, 5 months 9 days ago Results of the Predilife General Meeting Financial Results Actions Artificial Intelligence General Meeting PREDILIFE
BRIEF published on 06/11/2025 at 19:05, 5 months 23 days ago Amendment to the liquidity contract between PREDILIFE and TSAF Liquidity Contract Actions Artificial Intelligence PREDILIFE FASD
BRIEF published on 06/06/2025 at 20:20, 5 months 28 days ago Availability of the 2024 annual financial report by PREDILIFE Fundraising Financial Report PREDILIFE MammoRisk Certification Of Accounts
BRIEF published on 05/15/2025 at 08:05, 6 months 20 days ago PREDILIFE: 2024 Results and 2025 Outlook Growth 2024 PREDILIFE MammoRisk Partnerships 2025 Personalized Health
BRIEF published on 04/30/2025 at 18:35, 7 months 4 days ago Postponement of the publication of Predilife's 2024 annual results Financial Report PREDILIFE MammoRisk 2024 Results Subsidiary
Published on 12/05/2025 at 02:35, 2 hours 48 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 4 hours 23 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 18 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 23 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 1 hour 53 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 5 hours 32 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 8 hours 58 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 8 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 13 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 11 hours 23 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 11 hours 38 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 11 hours 39 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 22 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago Declaration of voting rights at the end of November 2025
